We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.36B
AUM Growth
-$370M
Cap. Flow
-$116M
Cap. Flow %
-2.16%
Top 10 Hldgs %
30.29%
Holding
272
New
25
Increased
53
Reduced
155
Closed
28

Top Buys

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$80.1M
2
META icon
Meta Platforms (Facebook)
META
+$49.8M
3
GTLS
Chart Industries
GTLS
+$45.7M
4
WOLF icon
Wolfspeed
WOLF
+$30.1M
5
MSGS icon
Madison Square Garden
MSGS
+$19.9M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$46.5M
2
ENPH icon
Enphase Energy
ENPH
+$38.5M
3
TSLA icon
Tesla
TSLA
+$35M
4
LFG
Archaea Energy Inc.
LFG
+$29.8M
5
CALX icon
Calix
CALX
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 33.08%
2 Healthcare 19.9%
3 Consumer Discretionary 17.94%
4 Industrials 9.82%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNLX
176
DELISTED
Renalytix plc American Depositary Shares
RNLX
$1.89M 0.04%
1,009,083
-176,780
-15% -$276K
IRTC icon
177
iRhythm Holdings
IRTC
$3.68B
$1.86M 0.03%
19,900
+8
+0% +$871
GTX icon
178
Garrett Motion
GTX
$4.87B
$1.82M 0.03%
238,782
+87
+0% +$611
LBRT icon
179
Liberty Energy
LBRT
$3.2B
$1.75M 0.03%
+109,410
New +$1.74M
AZUL
180
DELISTED
Azul
AZUL
$1.62M 0.03%
264,730
-696,580
-72% -$5.43M
RLAY icon
181
Relay Therapeutics
RLAY
$4.14B
$1.61M 0.03%
107,958
-35,562
-25% -$681K
PODD icon
182
Insulet
PODD
$9.57B
$1.55M 0.03%
5,272
+3
+0.1% +$827
ISEE
183
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.55M 0.03%
72,292
-33
-0% -$704
KRTX
184
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.49M 0.03%
7,571
-58
-0.8% -$12.4K
ATVI
185
DELISTED
Activision Blizzard
ATVI
$1.45M 0.03%
18,993
-1,146
-6% -$85.1K
CRM icon
186
Salesforce
CRM
$211B
$1.43M 0.03%
10,782
-5,976
-36% -$872K
CROX icon
187
Crocs
CROX
$5.37B
$1.41M 0.03%
+13,041
New +$1.15M
SHW icon
188
Sherwin-Williams
SHW
$77.8B
$1.38M 0.03%
5,795
+720
+14% +$166K
LESL icon
189
Leslie's
LESL
$4.4M
$1.37M 0.03%
5,594
-13,664
-71% -$3.8M
BRK.B icon
190
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.34M 0.02%
4,327
-8
-0.2% -$2.38K
CYTK icon
191
Cytokinetics
CYTK
$9.66B
$1.25M 0.02%
27,320
+1,485
+6% +$63.9K
UTHR icon
192
United Therapeutics
UTHR
$21.6B
$1.24M 0.02%
+4,451
New +$1.12M
SBUX icon
193
Starbucks
SBUX
$111B
$1.22M 0.02%
12,292
+2
+0% +$189
ASPN icon
194
Aspen Aerogels
ASPN
$402M
$1.19M 0.02%
100,828
-214
-0.2% -$2.45K
ATEN icon
195
A10 Networks
ATEN
$1.91B
$1.18M 0.02%
+70,696
New +$1.21M
CYBR
196
DELISTED
CyberArk
CYBR
$1.14M 0.02%
+8,794
New +$1.27M
VEEV icon
197
Veeva Systems
VEEV
$42.7B
$1.07M 0.02%
6,653
-2
-0% -$342
RVNC
198
DELISTED
Revance Therapeutics, Inc.
RVNC
$977K 0.02%
52,939
-3
-0% -$69
PEN icon
199
Penumbra
PEN
$12.6B
$976K 0.02%
+4,387
New +$858K
SONO icon
200
Sonos
SONO
$1.79B
$945K 0.02%
55,933
-1,167
-2% -$19K
6 7
8
9 10

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Gilder Gagnon Howe & Co held 272 positions worth $5.36B, down 6.5% from $5.73B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2022 filing shows 25 new, 53 increased, 155 reduced and 28 closed positions. Its largest new stake was Chart Industries: 284,553 shares worth $32.8M. The largest sale was Novo Nordisk, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2022 buy was Chart Industries: 284,553 shares worth $32.8M.
  • Gilder Gagnon Howe & Co added most to Canadian Pacific Kansas City in Q4 2022, an estimated $80.1M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $46.5M.
  • Gilder Gagnon Howe & Co fully exited Archaea Energy Inc. in Q4 2022, selling an estimated $29.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 30% of its $5.36B portfolio in Q4 2022.
  • Gilder Gagnon Howe & Co opened 25 new positions and closed 28 in Q4 2022.
  • Gilder Gagnon Howe & Co's portfolio value fell 6.5% quarter-over-quarter to $5.36B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2022, filed 14 Feb 2023.